By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


OptiNose AS 

Oslo Innovation Center
Gaustadalléen 21
Oslo    N-0349  Norway
Phone: 47-2295-8014 Fax: 47-2295-8098


Medical Device

Company News
OptiNose AS To Present At Innovations In Healthcare Executive Forum 3/30/2015 1:37:58 PM
OptiNose AS To Present At Nasal And Respiratory Drug Delivery Conferences 3/19/2015 11:34:01 AM
OptiNose AS To Present At The 35th Annual Cowen and Company Healthcare Conference 2/23/2015 11:21:38 AM
OptiNose AS Announces Publication Of Pivotal Phase 3 Results For Investigational Migraine Treatment Developed By Optinose Using Bi-Directional™ Breath Powered™ Technology 10/31/2014 10:03:11 AM
OptiNose AS Completes Series C-1 Financing 8/4/2014 7:18:53 AM
OptiNose AS Expands Senior Management Team With Three Key Appointments In Core Business Areas Of Operations, Regulatory Affairs And Commercialization 6/12/2014 8:06:11 AM
OptiNose AS Presents Positive Results From Phase 3 COMPASS Study 6/10/2014 6:39:06 AM
OptiNose AS Announces FDA Acceptance Of New Drug Application For AVP-825 For The Acute Treatment Of Migraine 3/27/2014 9:21:30 AM
OptiNose AS to Present Data Highlighting New Migraine Treatment at International Headache Congress 6/28/2013 9:24:11 AM
OptiNose AS Announces First Patient Enrolled in Phase III Study of Sumatriptan Powder Delivered Intranasally with Innovative Bi-directional Device 2/9/2012 7:48:40 AM